Spyre Therapeutics (SYRE) Shareholder's Equity (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 595,226.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.08 Bn
10 Spyre Therapeutics 5.55 Bn 5.55 Bn - 670.81 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 670.81 Mn
Dec 31, 2025 715.24 Mn
Sep 30, 2025 455.10 Mn
Jun 30, 2025 455.77 Mn
Mar 31, 2025 482.61 Mn
Dec 31, 2024 517.80 Mn
Sep 30, 2024 327.39 Mn
Jun 30, 2024 374.39 Mn
Mar 31, 2024 152.27 Mn
Dec 31, 2023 184.02 Mn
Sep 30, 2023 -245.40 Mn
Jun 30, 2023 -207.37 Mn
Mar 31, 2023 33.65 Mn
Dec 31, 2022 50.31 Mn
Sep 30, 2022 67.56 Mn
Jun 30, 2022 84.16 Mn
Mar 31, 2022 61.66 Mn
Dec 31, 2021 83.94 Mn
Sep 30, 2021 102.08 Mn
Jun 30, 2021 119.02 Mn
Mar 31, 2021 123.76 Mn
Dec 31, 2020 139.83 Mn
Sep 30, 2020 136.27 Mn
Jun 30, 2020 152.26 Mn
Mar 31, 2020 42.81 Mn
Dec 31, 2019 60.08 Mn
Sep 30, 2019 79.80 Mn
Jun 30, 2019 99.62 Mn
Mar 31, 2019 116.29 Mn
Dec 31, 2018 67.43 Mn
Sep 30, 2018 63.68 Mn
Jun 30, 2018 73.45 Mn
Mar 31, 2018 43.92 Mn
Dec 31, 2017 50.34 Mn
Sep 30, 2017 55.51 Mn
Jun 30, 2017 62.60 Mn
Mar 31, 2017 57.18 Mn
Dec 31, 2016 62.97 Mn
Sep 30, 2016 68.20 Mn
Jun 30, 2016 73.92 Mn
Mar 31, 2016 -26.61 Mn
Dec 31, 2015 -22.21 Mn